Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This study will contribute to the current literature that have compared joint injections with
steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain.
Currently steroid is the clinical standard for joint injections, however with repetitive use,
steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory
medication that does not cause the same joint damage and at a cheaper cost than steroid. The
investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac
provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12
weeks post injection. This would allow more frequent injections to control pain at a
decreased cost to the healthcare system.